Laserfiche WebLink
State of California-Fleaith andr Welfare Agency <br />••;• r, <br />Department of Health Services <br />Page 4 of 6 pages <br />License Number: 1294-39 <br />Amendment Number: 52 <br />19. Except as otherwise specifically provided by this license, radiopharmaceuticals to be administered to humans <br />shall be procured in prepackaged, precalibrated form from a supplier who is registered with the U. S. Food and <br />Drug Administration, or prepared and compounded, from a prescription, in accordance with the regulations of <br />the California Board of Pharmacy. <br />20. Except as otherwise specifically provided by this license, radioactive biologicals (including human serum <br />albumin) to be administered to humans shall be procured in prepackaged, precalibrated form from a supplier <br />who is licensed for the preparation and distribution of such products by the Division of Biologics Standards <br />of the National Institutes of Health, or U. S. Food and Drug Administration; or prepared in accordance with <br />the regulations of the California Board of Pharmacy. <br />21. Radioactive materials prepared, processed, or modified by the licensee shall not be administered to humans <br />except as specifically authorized by this license. <br />22. The licensee shall elute generators and process radioactive material with reagent kits in accordance with <br />instructions furnished by the manufacturer on the label attached to or in the leaflet or brochure that <br />accompanies the generator or reagent kit. <br />23. Technetium 99m labelled pharmaceuticals prepared by the licensee by aseptic addition of pertechnetate to <br />sterile, pyrogen free reagents may be administered to humans provided the radioassay of the final product is <br />determined with an overall error not exceeding ten percent. When the pharmaceutical is prepared from reagents <br />procured in the form of approved kits, the licensee must strictly follow all instructions and recommendations <br />contained in the package insert information; otherwise the pharmaceutical must be prepared and compounded <br />from a prescription in accordance with the regulations of the California Board of Pharmacy. <br />24. The licensee is authorized to hold radioactive materials with a physical half life of less than 65 days for decay <br />in storage before disposal in ordinary trash provided: <br />(a) Radioactive waste to be disposed of in this manner shall be held for decay in storage for no less than 10 <br />half lives. <br />(b) Before disposal as normal waste, radioactive waste shall be surveyed to determine that its radioactivity <br />cannot be distinguished from background. All radiation labels shall be removed or obliterated <br />25. Equipment for radiometric assay of pharmaceuticals, body fluids, excreta, or in -vitro assay samples shall be <br />calibrated to ensure reliability of data obtained The stability of the equipment shall be checked at least once <br />each day of use, using appropriate standards. <br />26. Nuclear medicine technology procedures shall be performed by nuclear medicine technologists pursuant to the <br />California Code of Regulations, Title 17, Subchapter 4.6. Such procedures shall be performed under the <br />supervision of individuals listed as authorized users on this license who meet the criteria specified in Section <br />30510. Certificates or special permits issued pursuant to Subchapter 4.6 shall be prominently displayed at the <br />facility(ies) authorized on this license. <br />